HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qing Zhu Selected Research

N-demethylsinomenine

1/2021N-Demethylsinomenine, an active metabolite of sinomenine, attenuates chronic neuropathic and inflammatory pain in mice.
3/2018Anti-allodynic effects of N-demethylsinomenine, an active metabolite of sinomenine, in a mouse model of postoperative pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qing Zhu Research Topics

Disease

79Neoplasms (Cancer)
09/2022 - 09/2006
24Inflammation (Inflammations)
01/2022 - 12/2006
23Infections
01/2022 - 10/2006
22Hypertension (High Blood Pressure)
07/2022 - 05/2010
19Hepatocellular Carcinoma (Hepatoma)
05/2022 - 01/2006
17Breast Neoplasms (Breast Cancer)
01/2022 - 04/2010
16Hypoxia (Hypoxemia)
10/2021 - 05/2010
13Carcinogenesis
12/2020 - 10/2013
10Fibrosis (Cirrhosis)
01/2022 - 12/2006
10Neoplasm Metastasis (Metastasis)
03/2018 - 03/2012
7Lung Neoplasms (Lung Cancer)
01/2022 - 09/2009
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2014
7Glioma (Gliomas)
01/2021 - 03/2007
7Prostatic Neoplasms (Prostate Cancer)
01/2018 - 04/2005
7Human Influenza (Influenza)
01/2017 - 06/2014
6Virus Diseases (Viral Diseases)
01/2021 - 08/2012
6Hyperalgesia
01/2021 - 05/2014
6Carcinoma (Carcinomatosis)
01/2021 - 09/2009
6Postoperative Pain
01/2021 - 05/2014
6Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2014
6Pain (Aches)
01/2021 - 05/2014
6Coronary Artery Disease (Coronary Atherosclerosis)
07/2016 - 05/2007
5Atherosclerosis
07/2022 - 01/2014
5Non-alcoholic Fatty Liver Disease
07/2022 - 01/2020
5Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 08/2013
5Aneurysm (Aneurysms)
01/2022 - 04/2010
5Chronic Renal Insufficiency
01/2021 - 06/2013
4Parkinson Disease (Parkinson's Disease)
11/2021 - 01/2014
4Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2011
4Stroke (Strokes)
01/2021 - 01/2014
4Systemic Vasculitis
01/2021 - 01/2018
4Neuralgia (Stump Neuralgia)
01/2021 - 05/2014
4Proteinuria
01/2021 - 01/2018
4Heart Failure
11/2020 - 10/2014
3Adenocarcinoma
05/2022 - 11/2018
3Myocardial Infarction
01/2022 - 01/2018
3Sarcoma (Soft Tissue Sarcoma)
01/2022 - 04/2020
3Vasculitis (Vasculitides)
01/2022 - 02/2019
3Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 12/2015
3Obstructive Sleep Apnea
01/2021 - 01/2021
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 01/2016
3Wounds and Injuries (Trauma)
01/2021 - 09/2010

Drug/Important Bio-Agent (IBA)

44Proteins (Proteins, Gene)FDA Link
03/2022 - 03/2006
30Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2013
16SaltsIBA
07/2022 - 05/2010
14Pharmaceutical PreparationsIBA
01/2022 - 10/2006
13AntigensIBA
01/2022 - 04/2005
12Small Interfering RNA (siRNA)IBA
09/2020 - 07/2005
9EnzymesIBA
05/2022 - 01/2014
9Messenger RNA (mRNA)IBA
01/2022 - 08/2008
8Antiviral Agents (Antivirals)IBA
12/2021 - 01/2013
8VaccinesIBA
12/2021 - 11/2006
8Long Noncoding RNAIBA
01/2021 - 08/2013
8Monoclonal AntibodiesIBA
01/2020 - 04/2005
7Biological ProductsIBA
05/2022 - 12/2006
7SodiumIBA
10/2021 - 11/2005
7Angiotensin IIIBA
02/2021 - 02/2011
7RNA (Ribonucleic Acid)IBA
01/2021 - 10/2005
7MicroRNAs (MicroRNA)IBA
01/2020 - 09/2015
6CholesterolIBA
07/2022 - 09/2014
6DNA (Deoxyribonucleic Acid)IBA
05/2022 - 06/2011
5Antihypertensive Agents (Antihypertensives)IBA
07/2022 - 01/2014
5ImmunosorbentsIBA
05/2022 - 01/2014
5Cysteine (L-Cysteine)FDA Link
01/2022 - 01/2011
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2012
5AutoantibodiesIBA
04/2017 - 01/2013
4LipidsIBA
07/2022 - 01/2021
4FructoseIBA
07/2022 - 07/2020
4AldosteroneIBA
03/2022 - 11/2020
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2017
4Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
10/2021 - 06/2013
4CytokinesIBA
01/2021 - 01/2013
4CreatinineIBA
01/2021 - 01/2018
4sinomenineIBA
01/2021 - 12/2014
4InflammasomesIBA
10/2020 - 03/2018
4Glycoproteins (Glycoprotein)IBA
03/2019 - 04/2005
4Peptides (Polypeptides)IBA
01/2015 - 01/2012
3Triglycerides (Triacylglycerol)IBA
07/2022 - 01/2021
3HDL LipoproteinsIBA
07/2022 - 01/2014
3CateninsIBA
07/2022 - 09/2015
3Drinking WaterIBA
07/2022 - 07/2020
3Sodium ChlorideFDA LinkGeneric
07/2022 - 07/2020
3NucleotidesIBA
05/2022 - 03/2018
3Caspase 3 (Caspase-3)IBA
01/2022 - 10/2014
3Lipase (Acid Lipase)FDA Link
01/2022 - 01/2014
3CarbohydratesIBA
01/2022 - 11/2018
3Indicators and Reagents (Reagents)IBA
01/2022 - 01/2020
3C-Reactive ProteinIBA
01/2022 - 02/2019
3Oxygen (Dioxygen)IBA
12/2021 - 10/2016
3AntibodiesIBA
11/2021 - 01/2016
3Butyric Acid (Butanoic Acid)IBA
02/2021 - 01/2017
3Acetates (Acetic Acid Esters)FDA Link
02/2021 - 01/2020
3Desoxycorticosterone Acetate (DOCA)FDA Link
02/2021 - 01/2020
3AlbuminsIBA
02/2021 - 01/2015
3Desoxycorticosterone (Deoxycorticosterone)IBA
02/2021 - 01/2020
3Poly I-CIBA
01/2021 - 01/2017

Therapy/Procedure

28Therapeutics
10/2022 - 10/2003
12Drug Therapy (Chemotherapy)
01/2022 - 05/2009
6Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 05/2014
4Immunotherapy
01/2022 - 04/2010